Medicines Safety Update
Medicines Safety Update
About this item
Full title
Medicines Safety Update
Publisher
Melbourne: Therapeutic Guidelines Limited
Journal title
Australian prescriber, 2011-08, Vol.34 (4), p.168
Language
English
Formats
Publication information
Publisher
Melbourne: Therapeutic Guidelines Limited
Subjects
More information
Scope and Contents
Contents
Cardiovascular precautions The PI states that venlafaxine causes a dose-related increase in resting heart rate and is associated with hypertension and increased serum cholesterol, which are presumed to be additive to other cardiovascular risk factors, and that venlafaxine should be used with caution in patients with unstable heart disease.5 In thes...
Alternative Titles
Full title
Medicines Safety Update
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2680211054
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2680211054
Other Identifiers
ISSN
0312-8008
E-ISSN
1839-3942
How to access this item
Log in as a Library member
